Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
474.5 USD | +0.89% | +1.23% | +16.61% |
07-02 | FDA Accepts Vertex Pharmaceuticals' New-Drug Application for Combination Therapy to Treat Cystic Fibrosis | MT |
07-02 | Vertex Gets Speedy FDA Review of Vanza Triple Cystic Fibrosis Therapy | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B | |
+125.88% | 11.29B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Incorporated announces an Equity Buyback for $500 million worth of its shares.